Indian Pharmacopoeia Dissolution Apparatus: Standards & Solutions

The Indian Pharmacopoeia dissolution apparatus is used by most medicine manufacturers in India to conduct quality control tests during the manufacturing stage. India is said to be the largest pharmacy in the world. Therefore, the Indian Pharmacopoeia has stringent dissolution testing requirements. The objective of this article is to identify the gaps in Indian Pharmacopoeia dissolution apparatus vis-a-vis market demands and advanced/novel techniques and assess the likely consequences of technological disruptions on quality of pharmaceutical products in India.

Requirements for the Indian Pharmacopoeia Dissolution Testing Apparatus

Dissolution testing for solid oral dosage forms is detailed in Indian Pharmacopoeia chapter 2.5.2. The Indian Pharmacopoeia recognizes two primary dissolution testing apparatus: Apparatus 1 (Paddle) and Apparatus 2 (Basket). These are also described in the USP and EP and therefore are considered harmonized.

Dissolution Apparatus Requirements:

•A hemispherical base glass vessel

•Stainless steel Type 316 for all other component parts

•Temperature of the system maintained at 36.5°C to 37.5°C

•Speed of the stirrer with a control tolerance of ± 4%

•Stirrer shaft deviation of ≤ ±2.0 mm from the center of the glass vessel

•The dissolution testing apparatus must be equipped to deaerate the dissolution medium prior to testing.

The dissolution test is used to assess regulatory compliance of tablets and capsules to the specified dissolution requirement, which is fundamentally important for the safety and effectiveness of the medicine.

Current Trends in Indian Dissolution Testing

The Indian pharmaceutical dissolution testing market has grown rapidly due to the speed of growth in Indian manufacturing. Major manufacturers in the current Indian market are Electronics India, Labindia Analytical, Electrolab, Panomex, and Veego Instrument Corporation.

Market Dynamics and Competitive Overview:

Manufacturer	Product Range	Market Position
Electronics India	Full dissolution line	Established player
Labindia Analytical	DS 14000 series	Advanced touchscreen
Electrolab	TDT series	Mumbai-based (1984)
RAYTOR	RT series	International compliance

Electrolab, headquartered in Mumbai since 1984, manufactures dissolution testers alongside media degassers, disintegration testers, friability testers, and leak testers. Labindia Analytical developed DS 14000 to include touchscreen functionality with ASTM and FDA mechanical calibration compliance.

Although there is a domestic market, many pharmaceutical companies in India still buy Indian Pharmacopoeia compliant dissolution testing instruments that offer automation and advanced features to meet international standards. The RAYTOR RT612 offers an increased level of automation with FDA 21 CFR Part 11 compliance for data integrity systems and dominates the local competition.

Horizontal Comparison: RT612 vs. Market Standards

When choosing an Indian Pharmacopoeia dissolution apparatus, laboratories have multiple parameters to evaluate. RAYTOR RT612 dissolution apparatus offers distinct advantages for several key performance parameters.

Compliance Parameter	RT612 Performance	IP/USP Requirement
Speed Range	0-300 rpm	0-200+ rpm
Speed Resolution	0.01 rpm	±4% tolerance
Steady Speed Error	≤ ±0.3 rpm	Within specified
Temp. Accuracy	≤ ±0.2℃	36.5–37.5℃
Temp. Resolution	0.01℃	Not specified
Centering Deviation	< ±2.0 mm	< ±2.0 mm
Shaft Wobble	< ±1.0 mm	Minimal required

RoT 612 offers the best precision with a steady speed error of ≤ ±0.3 rpm and a temperature accuracy within ≤ ±0.2°. These comply with the typical precision requirements of a dissolution test, temperature and speed, both of which are critical to a dissolution profile.

Compliance Certifications:

•Chinese Pharmacopoeia (ChP 0931)

•United States Pharmacopoeia (USP 711/724)

•European Pharmacopoeia (EP 2.9.3/4)

Vertical Analysis: Why Compliance Matters

Dissolution testing is the primary indicator of pharmaceutical quality. Testing for dissolution profile similarity factor (f2) ≥ 50, that is, testing for regulatory compliance from the customer's standpoint, is critical for a generic drug's market approval.

The effects of not complying include:

•Costly repeat testing due to unapproved regulatory submissions.

•Loss of competitive market position because of delayed product launches.

•Batch release may result inconsistent product quality and recall liability.

•Data integrity risks during regulatory audit.

Indian pharmaceutical manufacturers need to meet compliance for Indian Pharmacopoeia. When also catering to US and EU markets, the USP and EP requirements are also important. The RT612 is a suitable solution as it addresses the requirements of the three Pharmacopoeias and allows for testing across a number of export markets.

RT612 Dissolution Apparatus. Sophisticated Engineering for Indian Laboratories.

It offers a 12-position Dissolution testing system with the flexibility of single or dual control. The system is compliant to all ChP, USP and EP and features automation of drug control and provision of a real time control of speed and temperature and an extensive storage capacity for data.

Full Coverage of Dosage Forms:

•Oral tablets and capsules

•Topical patches

•Parenteral

•Semi-solid dosage forms

•Intrinsic dissolution rate measurement for APIs

Key Technical Features of the RT612 Dissolution Apparatus:

•Automatic Pre-Heating

With this feature, the system can start heating the water bath to the test temperature, well before the test starts, and it performs the heating in a time optimized manner, so that the water bath is set to the desired temperature and ready for the test. This ensures uniform test conditions for all test runs.

•Non-Resident Sampling Needles

Unlike conventional methods that introduce turbulence into the test vessel, the non-resident sampling needles are employed to facilitate very gentle sampling. The needle is automatically placed into the test vessel along the fluid volume to be withdrawn.

•Covered Dissolving Cups with Automatic Centering

Dissolving cups are centered automatically, expediting the installation with no need for manual positioning. This design also guarantees that the positioning of the vessel complies with the IP's requirement for the verticality for an angle of 90° ±0.5°.

•Paddle-Basket Co-Axial Design

The paddle-basket co-axial design can be applied to all regulatory testing procedures that are part of the pharmacopoeia. Importantly, no changes to the height of the system are needed to switch between dissolution methods. This feature can be a substantial timesaver to laboratories performing different dissolution assays for many regulatory submissions within a single business day.

•Smart Dual Speed Mode (Optional)

With the optional smart dual speed mode, the left and right six-shaft assemblies can be set to different rotation speeds. This allows for the testing of the two groups with different agitation speeds, thereby reducing the inter-group agitation time while maximizing the separation.

•Round Corner Water Bath

The round corner, one-piece water bath design ensures even circulation with no dead corners, resulting in uniform heating. Eliminating temperature gradients ensures consistent dissolution, independent of vessel positioning.

•Automatic Synchronous Dosing

With the automatic synchronous dosing feature, time discrepancies between dosing of the vessels are eliminated. Complete dosing time tracking provides an audit trail in support of FDA Part 11 requirements.

Data Integrity and Compliance:

The RT612's operating system supports FDA 21 CFR Part 11 and provides password-protected accounts with permissions and management for data and backups and audit trails. This feature is particularly beneficial to Indian pharmaceutical manufacturers targeting regulated markets where electronic records are upheld.

RAYTOR: Bridging Engineering Excellence Between India and China

RAYTOR Instruments manufactures top tier laboratory instruments and scientific tools. Since our incorporation in 2015, we have been engaged in the design and manufacturing of analytical instruments. We carry out application tests in Pharmaceutical field for Drug Dissolution & Diffusion. Additionally, we provide services for transdermal studies.

RAYTOR is optimizing its international infrastructure, evidenced through its rapid response global sales network and 24-hour sales team. Our variety of products can assist various dosage forms (oral, transdermal, subcutaneous) in both pre-formulation and quality control.

With the implementation of 6S production management, RAYTOR demonstrates its commitment to lean production through the fulfillment of customer orders and the sustainment of quality in all the company's output.

Conclusion

The choice of Indian Pharmacopoeia dissolution apparatus is a significant selection for pharmaceutical quality control laboratories. The RT612 model, from RAYTOR, provides an ideal solution, as it meets the pharmacopoeia standards and incorporates automation to diminish the variability effects of the laboratory. The RT612, with its control of temperature and test parameters, fulfilled the precision and control required to be compliant with FDA's Part 11 regulation and gained both Indian and International market approval.

For Indian pharmaceutical manufacturers seeking Indian Pharmacopoeia dissolution apparatus that exceeds standard compliance requirements, RAYTOR's RT612 provides a compelling solution backed by comprehensive international certification and advanced engineering.

RAYTOR: Make scientific experiments easier.

�� Phone: +86 (20) 3160 8901

✉️ Email: sales@raytor.com

�� Address: Youchegang Town, Xiuzhou District, Jiaxing, Zhejiang, China

•Product R&D Platform: Comprehensive platform dedicated to independent development of pharmaceutical analytical instruments

•Application Experiment Center: Certified senior pharmaceutical experts collaborating with leading universities and pharmaceutical companies in joint laboratories

•Global Sales Network: 24-hour rapid response with active international market expansion

FAQs

Q1: What are the benefits of the smart dual speed mode?

A1: The left and right six shafts can be set to independent speeds, which allows two dissolution tests to be conducted at the same time.

Q2: Does the RT612 accommodate the paddle and basket methods of the IP?

A2: The RT612 has both paddle and basket designs that are co-axial, and allow for a method change with no height re-adjustment.

Q3: How many test locations are available in the RT612?

A3: The RT612 is a 12-position dissolution testing system, which allows testing in 12 vessels at once.

Q4: Does RT612 require manual adjustment to center the vessel?

A4: No. Self-centering is a feature of the dissolving cup design. For IP requirements, the shaft centering deviation is held at ±2.0 mm, eliminating the need for manual adjustment.

Q5: Can Indian Pharmaceutical Labs use RAYTOR's RT612?

A5: Yes. RAYTOR services customers worldwide and, for customers in India, provides a 24-hour rapid response via the international sales network.